Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
J.KasteleijnE.FryA
No conditional release exists in the workflow, so a partial pass puts the lot on hold pending resolution
Early indicators include persistent headaches, blurred vision, and skin changes such as dryness, peeling, and photosensitivity [4]
Current research efforts focused on the precise modulation of NO or selective targeting of NO-related pathways represent a promising frontier for enhancing CRC treatment efficacy
A novel HIF-2 targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPR(ER) axis
US$ 25.20
US$ 29.59
US$ 23.92
US$ 21.20
US$ 20.99
US$ 26.62
US$ 26.33
US$ 28.38
US$ 29.57
US$ 23.27
